Technology

If you are considering Eli Lilly's upcoming oral GLP-1 medication, Orforglipron, expected in 2026, it is important to have a clear framework for evaluation. While the medication is still in development, understanding key factors like efficacy, safety profile, dosing convenience, and cost can help you make an informed decision...